SCHEMBL22784164

SCHEMBL22784164

CN1C2CC(OC(=O)N3CCc4ccccc4[C@@H]3c3ccc(F)cc3)CC1C2

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 10/20 0.61
KCNH2 Q12809 2/20 0.61
TRPM8 Q7Z2W7 4/20 0.49
CHRM2 P08172 2/20 0.49
CHRM1 P11229 2/20 0.49
CACNA1F O60840 1/20 0.49
CHRM4 P08173 1/20 0.49
CHRM5 P08912 1/20 0.49
KCNE1 P15382 1/20 0.49
KCNQ1 P51787 1/20 0.49
CACNA1D Q01668 1/20 0.49
CACNA1S Q13698 1/20 0.49
CACNA1C Q13936 1/20 0.49
SCN5A Q14524 1/20 0.49
KCND3 Q9UK17 1/20 0.49
TRPV1 Q8NER1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22784221 0.92 CHRM3 (0.57) CHRM3KCNH2TRPM8CHRM2CHRM1
SCHEMBL21095697 0.92 CHRM3 (0.58) CHRM3KCNH2TRPM8CHRM2CHRM1
SCHEMBL22784237 0.87 CHRM3 (0.68) CHRM3KCNH2TRPM8CHRM2CHRM1
SCHEMBL23562324 0.86 CHRM3 (0.64) CHRM3KCNH2TRPM8CHRM2CHRM1
SCHEMBL23562419 0.86 CHRM3 (0.64) CHRM3KCNH2TRPM8CHRM2CHRM1
SCHEMBL23562279 0.86 CHRM3 (0.64) CHRM3KCNH2TRPM8CHRM2CHRM1
SCHEMBL30059407 0.86 CHRM3 (0.64) CHRM3KCNH2TRPM8CHRM2CHRM1
SCHEMBL30061460 0.86 CHRM3 (0.64) CHRM3KCNH2TRPM8CHRM2CHRM1
SCHEMBL25126221 0.86 CHRM3 (0.61) CHRM3KCNH2TRPM8CHRM2CHRM1
SCHEMBL25126854 0.86 CHRM3 (0.61) CHRM3KCNH2TRPM8CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239892-A1 COMPOUNDS FOR MODULATION OF CD68 AND USES THEREOF ARKUDA THERAPEUTICS (US) 2023-12-14 WO disclosed
WO-2020252222-A1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME ARKUDA THERAPEUTICS (US) 2020-12-17 WO disclosed